Form 4 for MRNA Moderna
Accepted 2025-10-06 00:00:00 ET · period of report 2025-10-02 · accession 0001682852-25-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-06 | 2025-10-02 | MRNA | Hussain Abbas | Dir | M - OptEx | — | +1,439 | 2,019 | +248% | — |
| D | 2025-10-06 | 2025-10-02 | MRNA | Hussain Abbas | Dir | M - OptEx | $0.00 | -1,439 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-02 | M | A | 1,439 | — | 2,019 | D | — | — | (F2) The shares subject to this restricted stock unit award vested in full on October 2, 2025. |
| 2 | Derivative | Restricted Stock Units | 2025-10-02 | M | D | 1,439 | $0.00 | 0 | D | — · — to — | 1,439 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The shares subject to this restricted stock unit award vested in full on October 2, 2025. |